CORRECTION article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Correction: The active constituent of pine needle oil, bornyl acetate, suppresses NSCLC progression by inhibiting the PI3K/AKT/ABCB1 signaling axis
Provisionally accepted
Jieheng Wu1*
Jiaming Ren1Lu Wang1Zeyang Yang1Xuanyin Wang1Ziyi Tu1Xinlei Liu1Ye Wang2Yaxuan Cao1Xu Zhu1Long Li1Maoqin Lu1Ying Zhang1Jinyi Wu1Yu Cao1- 1Guizhou Medical University, Guiyang, China
- 2Guiyang Healthcare Vocational University, Guiyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Wrong content There was a mistake in figure5B as published. During a recent review of the figures, we discovered a duplication in Figure 5B, specifically in the panel showing the in vivo imaging results of the saline control group on Day 22. The images for the third and fourth mice were inadvertently repeated during the figure preparation process. We have carefully rechecked the original data and confirmed that the error occurred during figure assembly and layout, and not in the experimental data itself. The underlying findings and conclusions of the study remain valid and unaffected. The corrected figure5B appears below.The original version of this article has been updated.Reminder: Figures, tables, and images will be published under a Creative Commons CC-BY license and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, to follow any citation instructions requested by third-party rights holders, and cover any supplementary charges.
Keywords: Bornyl acetate, NSCLC, PI3K/AKT, ABCB1, tumor progression
Received: 23 Oct 2025; Accepted: 30 Oct 2025.
Copyright: © 2025 Wu, Ren, Wang, Yang, Wang, Tu, Liu, Wang, Cao, Zhu, Li, Lu, Zhang, Wu and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jieheng Wu, immunewjh@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.